Institutional shares held 91.8 Million
1.03M calls
10.1K puts
Total value of holdings $874M
$9.82M calls
$96K puts
Market Cap $377M
39,576,700 Shares Out.
Institutional ownership 232.07%
# of Institutions 146


Latest Institutional Activity in ORIC

Top Purchases

Q2 2025
Sr One Capital Management, LP Shares Held: 4.51M ($43M)
Q2 2025
Vr Adviser, LLC Shares Held: 6.6M ($62.8M)
Q2 2025
Point72 Asset Management, L.P. Shares Held: 2.85M ($27.1M)
Q2 2025
Nea Management Company, LLC Shares Held: 4.12M ($39.2M)
Q2 2025
Nextech Invest, Ltd. Shares Held: 7.16M ($68.2M)

Top Sells

Q2 2025
Eco R1 Capital, LLC Shares Held: 1.62M ($15.4M)
Q2 2025
State Street Corp Shares Held: 1.63M ($15.5M)
Q2 2025
Superstring Capital Management LP Shares Held: 345K ($3.28M)
Q2 2025
Frazier Life Sciences Management, L.P. Shares Held: 1.07M ($10.1M)
Q2 2025
Silverarc Capital Management, LLC Shares Held: 1.8M ($17.1M)

About ORIC

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.


Insider Transactions at ORIC

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
191K Shares
From 5 Insiders
Exercise of conversion of derivative security 163K shares
Open market or private purchase 28K shares
Sell / Disposition
102K Shares
From 3 Insiders
Open market or private sale 102K shares

Track Institutional and Insider Activities on ORIC

Follow Oric Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC